Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Net Income (2020 - 2025)

Treace Medical Concepts' Net Income history spans 6 years, with the latest figure at -$6.7 million for Q4 2025.

  • For Q4 2025, Net Income fell 989.66% year-over-year to -$6.7 million; the TTM value through Dec 2025 reached -$56.7 million, down 1.12%, while the annual FY2025 figure was -$56.7 million, 1.12% down from the prior year.
  • Net Income reached -$6.7 million in Q4 2025 per TMCI's latest filing, up from -$16.4 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$619000.0 in Q4 2024 to a low of -$21.3 million in Q2 2024.
  • Average Net Income over 5 years is -$11.1 million, with a median of -$12.2 million recorded in 2022.
  • Peak YoY movement for Net Income: surged 90.29% in 2024, then crashed 989.66% in 2025.
  • A 5-year view of Net Income shows it stood at -$6.6 million in 2021, then surged by 38.75% to -$4.1 million in 2022, then tumbled by 57.26% to -$6.4 million in 2023, then soared by 90.29% to -$619000.0 in 2024, then plummeted by 989.66% to -$6.7 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Net Income are -$6.7 million (Q4 2025), -$16.4 million (Q3 2025), and -$17.5 million (Q2 2025).